Myriad Genetics, Inc.
Myriad Genetics, Inc., a leading player in the precision medicine industry, is headquartered in the United States. Founded in 1991, the company has established itself as a pioneer in genetic testing and molecular diagnostics, focusing on areas such as oncology, women's health, and hereditary cancer. With a commitment to advancing healthcare through innovative solutions, Myriad offers a range of unique products and services, including genetic tests that provide critical insights for personalised treatment plans. The company has achieved significant milestones, including the development of the first FDA-approved genetic test for breast cancer risk assessment. Recognised for its contributions to the field, Myriad Genetics holds a strong market position, continually striving to enhance patient outcomes through cutting-edge technology and research.
DitchCarbon Score
How does Myriad Genetics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Myriad Genetics, Inc.'s score of 18 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Myriad Genetics, Inc.'s reported carbon emissions
Myriad Genetics, Inc., headquartered in the US, currently does not have publicly available data on its carbon emissions, as there are no reported figures for emissions in kg CO2e. Additionally, the company has not outlined specific reduction targets or initiatives related to carbon emissions. Without concrete emissions data or defined climate commitments, it is challenging to assess their environmental impact or sustainability efforts. As the industry increasingly prioritises climate action, Myriad Genetics may need to establish clear goals and strategies to align with global climate standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Myriad Genetics, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
